Insider Trading History of Ichim Thomas

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Ichim Thomas since 2008. This trader's CIK number is 1429928. At the time of last reporting, Ichim Thomas was the Officer of Creative Medical Technology Holdings, Inc.. (stock ticker symbol CELZ). Also see all insider trading activities at Creative Medical Technology Holdings, Inc..

Note that in the past Ichim Thomas also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Medistem Laboratories, Inc. (MDSM.OB) by Ichim Thomas

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 MDSM.OB 18,000 $900 0 $0 0 $0

Yearly summary of insider trading at Creative Medical Technology Holdings, Inc. (CELZ) by Ichim Thomas

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 CELZ 0 $0 4,350,000 $132,000 10,000,000 $40,000


Insider trading activities at 2 companies by Ichim Thomas:

1. Medistem Laboratories, Inc. (MDSM.OB)

2. Creative Medical Technology Holdings, Inc. (CELZ)

Table 1. Insider trading of Medistem Laboratories, Inc. (MDSM.OB) by Ichim Thomas

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-03-24 MDSM.OB Buy 18,000 .05 900

Table 2. Insider trading of Creative Medical Technology Holdings, Inc. (CELZ) by Ichim Thomas

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-07-01 CELZ Sale 1,450,000 .03 43,500
2021-07-01 CELZ Sale 1,400,000 .03 42,000
2021-07-01 CELZ Sale 1,500,000 .03 46,500
2021-06-01 CELZ Option Ex 10,000,000 .00 40,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ichim Thomas (Officer of Creative Medical Technology Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.